Inventaire - i tuoi amici e le tue comunità sono la tua biblioteca

Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure)

autore

Adam D. DeVore

Paul A. Heidenreich

Deepak L. Bhatt

2000 -

Gregg C. Fonarow

Adrian F. Hernandez

Roland A. Matsouaka

Clyde Yancy

1958 -

Shubin Sheng

pubblicato in: American Journal of Cardiology

data di pubblicazione: 2018-12-03

lingua: inglese

argomento principale: insufficienza cardiaca, Emoglobina glicata

Cita articoli 27

Data

Titolo

Autori

2018-01-31

Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.

Nicole L Spartano, Jason Hy Wu, Mary Cushman, Khurram Nasir, Clifton Callaway, Myriam Fornage, Paul Muntner, Pamela L. Lutsey, Carmen R Isasi, Lynda D. Lisabeth, Emelia J. Benjamin, Cathleen Gillespie, Mathew J Reeves, Suzanne E Judd, Daniel T. Lackland, Salim S. Virani, David B. Matchar, Michael E. Mussolino, Latha P Palaniappan, Matthew D Ritchey, Wayne D Rosamond, Joshua Z Willey, Stephanie E Chiuve, Rajat Deo, Sarah D de Ferranti, Monik C Jiménez, Lori Chaffin Jordan, Chris T Longenecker, Kunihiro Matsushita, Connie W Tsao, Jenifer H Voeks, Heather M Alger, Judith H Lichtman, Martin O'Flaherty
2017-10-31

Anemia in Heart Failure: Still Relevant?

Dirk J van Veldhuisen
2016-05-20

Association of HbA1c with hospitalization and mortality among patients with heart failure and diabetes
2016-03-18

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis

Jason Hy Wu, Johan Sundström, Bruce Neal
2015-07-07

Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Erik Magnus Ohman, Sidney C Smith, Deepak L. Bhatt, Peter Wilson, Kim A. Eagle
2014-07-02

Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study

Finlay A McAlister
2014-09-04

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial

Eugene Braunwald, Jacob A. Udell, Deepak L. Bhatt
2013-10-03

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Eugene Braunwald, Jacob A. Udell, Deepak L. Bhatt, Michel Krempf, Walter P Abhayaratna, Tomasz Mazurek
2012-12-01

Measurement of hemoglobin A(1c): a new twist on the path to harmony
2012-02-14

Current controversies in the use of haemoglobin A1c

Matthew Hare, Paul Zimmet
2012-10-25

Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta-analysis
2012-03-27

Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus
2011-10-13

Diabetes and the risk of heart failure

Ramachandran S. Vasan
2011-08-09

Diabetes, quality of care, and in-hospital outcomes in patients hospitalized with heart failure

Gregg C. Fonarow, Adrian F. Hernandez, Paul A. Heidenreich, Xin Zhao
2010-05-18

The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study

Alain G. Bertoni, Josef Coresh, Elizabeth Selvin
2009-02-19

Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus

Kevin M. Goode, Stephen L. Atkin, John Cleland
2009-07-01

Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes
2008-10-01

HbA 1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study

Elizabeth Selvin
2008-08-01

The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality

Hertzel C. Gerstein, Karl Swedberg, Salim Yusuf, John McMurray, Marc A Pfeffer, Eric L Michelson, Jonas Carlsson Almlöf, CHARM Program Investigators
2007-08-01

Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Gregg C. Fonarow, Mihai Gheorghiade, Karen Chiswell, Christopher M O'Connor, Clyde Yancy, Wendy Gattis Stough, William T Abraham, Barry H. Greenberg, Nancy M Albert, Jie Lena Sun
2007-05-29

Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program

Elizabeth Barrett-Connor, Diabetes Prevention Program Research Group, John M. Lachin, Steven E. Kahn, Steven M. Haffner, Gabriel I Uwaifo
2006-01-01

An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure

Gregg C. Fonarow
2004-11

The American Heart Association Get With The Guidelines program
2003-09-01

The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial

Brian D. Lowes, Steven M. Haffner
2003-10-01

Using "get with the guidelines" to improve cardiovascular secondary prevention
2001-06-01

Glycemic control and heart failure among adult patients with diabetes

Assiamira Ferrara
2001-08-01

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction

Articolo - wd:Q64355431

Benvenuto su Inventaire

la biblioteca dei tuoi amici e della tua comunità

ulteriori informazioni